Huimin Wang - Jan 7, 2022 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
CVP, Japan & Intercontinental
Signature
Linda J. Park, Attorney-in-Fact
Stock symbol
EW
Transactions as of
Jan 7, 2022
Transactions value $
-$637,540
Form type
4
Date filed
1/7/2022, 05:06 PM
Previous filing
Dec 10, 2021
Next filing
Feb 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Options Exercise $138K +6.35K +6.48% $21.76 104K Jan 7, 2022 Direct F1
transaction EW Common Stock Sale -$776K -6.35K -6.08% $122.16 98K Jan 7, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Employee Stock Option (Right to Acquire) Options Exercise $0 -6.35K -50% $0.00 6.35K Jan 7, 2022 Common Stock 6.35K $21.76 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.